Skip to main content

George Simeon

In the past year, 3 open-market purchase filings worth $22.4M and 1 sale filing worth $32.0K.

Current role at each company

Show 4 more companies

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
$22.4M
3 filings
Sold
$32.0K
1 filing
Net
+$22.4M
Bought minus sold
Companies
3
With open-market trades

Trades

Every Form 4 that lists George Simeon as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

ODTX Odyssey Therapeutics, Inc.

10% Owner2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 11, 2026 (view filing)9:11 PM ETMay 11Same dayGeorge Simeon and 1 other10% OwnerSSale−1.78K$18.00−$32.0K−0.2%814.9K after3 lots
May 11, 2026 (view filing)9:11 PM ETMay 11Same dayGeorge Simeon and 1 other10% OwnerPPurchase+555.6K$18.00+$10.0M+121.0%1.01M after3 lots

AVLN Avalyn Pharma Inc.

10% Owner1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 1, 2026 (view filing)6:46 PM ETMay 1Same dayGeorge Simeon and 1 other10% OwnerPPurchase+555.6K$18.00+$10.0M+98.1%1.12M after2 lots

ZBIO Zenas BioPharma, Inc.

10% Owner2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Oct 14, 2025 (view filing)5:14 PM ETOct 95 daysGeorge Simeon and 1 other10% OwnerPPurchase+126.3K$19.00+$2.40M+7.1%1.92M after2 lots
Sep 16, 2024 (view filing)8:51 PM ETSep 16Same dayGeorge Simeon and 1 other10% OwnerPPurchase+2.24M$17.00+$38.0MNew position1.11M after3 lots

CRSP CRISPR Therapeutics AG

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 17, 2025 (view filing)Jul 161 dayGeorge SimeonDirectorPPurchase+989.8K$52.03+$51.5M+133.7%1.73M after3 lots

NKTX Nkarta, Inc.

Director2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 28, 2024 (view filing)Mar 271 dayGeorge SimeonDirectorPPurchase+2.00M$10.00+$20.0MNew position451.7K after2 lots
Apr 29, 2022 (view filing)Apr 281 dayGeorge SimeonDirectorPPurchase+1.33M$15.00+$20.0MNew position666.7K after2 lots

EFTR eFFECTOR Therapeutics, Inc.

10% Owner1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 29, 2023 (view filing)5:07 PM ETNov 272 daysGeorge Simeon and 5 others10% OwnerSSale−609.2K$0.6065−$369.5K−25.1%1.82M after2 lots

ACLX Arcellx, Inc.

10% Owner2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 15, 2023 (view filing)6:16 PM ETMay 114 daysGeorge Simeon and 5 others10% OwnerSSale−1.01M$45.01−$45.6M−37.9%1.66M after4 lots
Feb 10, 2022 (view filing)8:41 AM ETFeb 82 daysGeorge Simeon and 5 others10% OwnerPPurchase+1.67M$15.00+$25.0M+454.7%2.03M after2 lotsDuplicate filing

DSGN Design Therapeutics, Inc.

Director, 10% Owner1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 20, 2022 (view filing)Dec 16-204 daysGeorge SimeonDirector, 10% OwnerPPurchase+900.0K$8.41+$7.57M+16.0%6.53M after3 lots